Literature DB >> 7534130

Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization.

C L Li1, G R Johnson.   

Abstract

Murine bone marrow cells were fractionated by fluorescence-activated cell sorting into Rh123lo Lin- c-kit+ Ly6A+, Rh123hi Lin-c-kit+ Ly6A+, and Lin- c-kit+ Ly6A- populations within which most, if not all, of the hematopoietic activities of the marrow resided. The Rh123lo Lin- c-kit+Ly6A+ cells, which consist exclusively of small- or medium-sized lymphocyte-like cells, are highly enriched for long-term hematopoietic in vivo repopulating cells. The enrichment factor for these cells from the marrow was estimated as 2,000-fold. The Rh123hi Lin- c-kit+ Ly6A+ cells, although also highly enriched for day-12 spleen colony-forming units, were relatively depleted of long-term in vivo repopulation capacity. Most, if not all Lin- c-kit+ Ly6A- cells were Rb123hi. In contrast to both Rh123lo and Rh123hi Lin- c-kit+ Ly6A+ stem cell populations, the Lin- c-kit+ Ly6A- cells can be stimulated to proliferate in vitro in the presence of single cytokines, which is a characteristic of committed progenitor cells. No marked synergistic interactions between individual cytokines were observed with this cell population. Both Rh123hi Lin- c-kit+ Ly6A+ mature stem cell and Lin- c-kit+ Ly6A- progenitor cell populations displayed in vivo repopulation kinetics resembling those of the putative short-term hematopoietic repopulating cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534130

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.

Authors:  Bart Lammers; Prakash G Chandak; Elma Aflaki; Gijs H M Van Puijvelde; Branislav Radovic; Reeni B Hildebrand; Illiana Meurs; Ruud Out; Johan Kuiper; Theo J C Van Berkel; Dagmar Kolb; Guenter Haemmerle; Rudolf Zechner; Sanja Levak-Frank; Miranda Van Eck; Dagmar Kratky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-28       Impact factor: 8.311

Review 2.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Hematopoietic stem cell aging: mechanism and consequence.

Authors:  Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  Exp Gerontol       Date:  2007-01-31       Impact factor: 4.032

Review 4.  The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man.

Authors:  Daniel A Zlotoff; Benjamin A Schwarz; Avinash Bhandoola
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

Review 5.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 6.  Communications between bone cells and hematopoietic stem cells.

Authors:  R L Porter; L M Calvi
Journal:  Arch Biochem Biophys       Date:  2008-04-07       Impact factor: 4.013

Review 7.  The niche as a target for hematopoietic manipulation and regeneration.

Authors:  Rialnat A Lawal; Laura M Calvi
Journal:  Tissue Eng Part B Rev       Date:  2011-09-27       Impact factor: 6.389

8.  Lin-c-kit(+) BM-derived stem cells repair Infarcted Heart.

Authors:  M Khan; S Mohsin; Sn Khan; S Riazuddin
Journal:  J Stem Cells Regen Med       Date:  2010-04-05

Review 9.  microRNA and stem cell function.

Authors:  Steven Hatfield; Hannele Ruohola-Baker
Journal:  Cell Tissue Res       Date:  2007-11-07       Impact factor: 5.249

10.  The pharmacological activation of adenosine A1 and A 3 receptors does not modulate the long- or short-term repopulating ability of hematopoietic stem and multipotent progenitor cells in mice.

Authors:  Michal Hofer; Milan Pospíšil; Zuzana Hoferová; Denisa Komůrková; Petr Páral; Filipp Savvulidi; Luděk Sefc
Journal:  Purinergic Signal       Date:  2012-12-15       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.